hero-bg
Drive your

Healthcare breakthroughs

with our formidable R&D expertise and an extensive range of high-quality Active Pharmaceutical Ingredients and Intermediates, powered by complete backward integration.

Discover our product portfolio

APIs | CEP/EDMP approved

  • Verapamil

    Anti-Arrhythmic

    • Filing status

      CEP/EDMF, NMPA, USDMF

    • Capacity

      40 MT Annually

  • Valacyclovir

    Antiviral

    • Filing status

      Brazil DMF, CEP/EDMF, Iran DMF, PPB-MOH-KENYA, Singapore DMF, TGA DMF, USDMF

    • Capacity

      50 MT Annually

  • Levothyroxine Sodium

    Hormones

    • Filing status

      CEP/EDMF, Iran DMF, NMPA, USDMF

    • Capacity

      500 KG Annually

  • Dronaderone

    Anti-Arrhythmic

    • Filing status

      ASMF, CEP/EDMF, Israil, MFDS, NMPA, USDMF

    • Capacity

      50 MT Annually

  • Raltegravir

    Antiretroviral medication

    • Capacity

      5 MT Annually

  • Levetiracetam

    Anti-Epileptic

    • Filing status

      CEP/EDMF, USDMF

    • Capacity

      200 MT Annually

  • Flecainide Acetate

    Anti-Arrhythmic

    • Filing status

      CEP/EDMF

    • Capacity

      50 MT Annually

  • Clozapine

    Anti-inflammatory

    • Filing status

      CEP/EDMF, Russia DMF, TPD Canada, USDMF

    • Capacity

      70 MT Annually

  • Acyclovir

    Antiviral

    • Filing status

      CEP/EDMF, TDMF, USDMF

    • Capacity

      200 MT

APIs | USDMF approved

  • Tafamidis

    Transthyretin Stabilizer

    • Filing status

      USDMF

    • Capacity

      1,800 MT Annually

  • Dronaderone

    Anti-Arrhythmic

    • Filing status

      ASMF, CEP/EDMF, Israil, MFDS, NMPA, USDMF

    • Capacity

      50 MT Annually

  • Sulindac

    Anti-inflammatory

    • Filing status

      USDMF

    • Capacity

      30 MT Annually

  • Raltegravir

    Antiretroviral medication

    • Capacity

      5 MT Annually

  • Levothyroxine

    Hypothyroidism

    • Filing status

      CEP/EDMF, NMPA, USDMF

    • Capacity

      1 MT Annually

  • Levetiracetam

    Anti-Epileptic

    • Filing status

      CEP/EDMF, USDMF

    • Capacity

      200 MT Annually

  • Dabigatran Etexilate Mesilate

    Anti-Coagulant

    • Filing status

      CEP/EDMF, USDMF

    • Capacity

      35 MT Annually

  • Clozapine

    Anti-inflammatory

    • Filing status

      CEP/EDMF, Russia DMF, TPD Canada, USDMF

    • Capacity

      70 MT Annually

  • Bilastine

    Anti Histamine

    • Filing status

      ASMF, USDMF

    • Capacity

      50 MT Annually

R&D

At the heart of our operation lies a dynamic R&D nucleus. Our accomplished team, comprising leading scientists and experienced chemists, propels advanced research and innovation. Boasting a formidable cadre of 60 R&D scientists, alongside 65 analytical experts, we forge a pathway to progress. Backed by 10 doctorates, our technical acumen fuels pioneering discoveries, underpinned by state-of-the-art infrastructure.

Manufacturing Units

Global expertise, strategic execution, and scalable capacity with precision. FDA-approved and cGMP-compliant production sites ensuring reliability, agility, and continuous innovation.

  • Cryogenic capability

  • Hydrogenation capability

Accreditations

We manufacture a diverse and differentiated product portfolio of APIs by developing innovative and cost-efficient manufacturing processes in full compliance with environmental, health and safety, and international GMP standards.